Meiji Yasuda America’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.3M Buy
15,267
+4,195
+38% +$4.29M 3.06% 8
2026
Q1
$10.2M Buy
11,072
+304
+3% +$308K 2.52% 10
2025
Q4
$11.6M Buy
+10,768
New +$10.3M 2.66% 9

Other funds holding LLY

Meiji Yasuda America's LLY Position: Q2 2026 in Review

Meiji Yasuda America increased its Eli Lilly (LLY) stake by 38% in Q2 2026, buying an estimated $4.29M and bringing the position to 15,267 shares worth $18.3M. The position accounts for 3.06% of the portfolio, ranked #8.

Meiji Yasuda America first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,617 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Meiji Yasuda America held 15,267 shares of Eli Lilly worth $18.3M as of Q2 2026.
  • Meiji Yasuda America bought 4,195 Eli Lilly shares in Q2 2026, an estimated $4.29M.
  • Eli Lilly made up 3.06% of Meiji Yasuda America's portfolio in Q2 2026, its #8 holding.
  • Meiji Yasuda America first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,617 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Meiji Yasuda America's 13F filing for Q2 2026, filed 28 Jul 2026.